Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors.

ABSTRACT:

SUBMITTER: Yang D 

PROVIDER: S-EPMC7896746 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature